<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08426950602422</udiDi>
    <basicUdiDi>84269506024226L</basicUdiDi>
    <tradeName>HemosIL AcuStar ADAMTS13 Activity</tradeName>
    <deviceName>HemosIL AcuStar ADAMTS13 Activity</deviceName>
    <manufacturerName>Instrumentation Laboratory Company</manufacturerName>
    <manufacturerSrn>US-MF-000035586</manufacturerSrn>
    <authorisedRepresentativeName>Instrumentation Laboratory SpA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000008169</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020311</emdnCode>
    <emdnDescription>ADAMTS13 (ACTIVITY, AG, AB, INHIBITOR) SPECIFIC VON WILLEBRAND FACTOR (VWF) - CLEAVING PROTEASE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>0009802048</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T10:11:37.064Z</lastUpdated>
  </row>
</eudamedExport>